nach oben

Inflammopharmacology

Erschienen in:

28.10.2016 | Editorial

Our silver jubilee/anniversary 1991–2016

verfasst von: Michael Whitehouse

Erschienen in: Inflammopharmacology | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Excerpt

After a 3-year period of incubation, the journal, Inflammopharmacology, was launched in 1991. The timing was particularly appropriate as a related journal, Agents and Actions, formerly Helvetica Pharmaceutica Acta, was to mutate into a more physiological journal called “Inflammation Research”. The pharmacological and toxicological aspects of inflammation and its regulation by medicinal xenobiotics were then deemed worthy of a better fate than being lost by neglect. …

Nur mit Berechtigung zugänglich

Disannayake DMBT, Faoagali J, Laroo H, Hancock G, Whitehouse M (2014) Efficacy of some colloidal silver preparations and silver salts against Proteus bacteria, one possible cause of rheumatoid arthritis. Inflammopharmacology 22:73–77CrossRef

Kean WF, Kean IRL (2008) Clinical pharmacology of gold. Inflammopharmacology 16:112–125CrossRefPubMed

Weiping L, Yang YK, Xiong XZ, Cheng ZH, Chen ZQ, Li SL (1997) Coordination of copper with aspirin enhances its anti-platelet aggregation activity. Inflammopharmacology 5:133–138CrossRefPubMed

Whitehouse MW (2015a) Silver pharmacology. Progr Drug Res 70:237–273CrossRef

Whitehouse MW (2015b) Microbes as trigger/sustainers of chronic immune-mediated inflammatory diseases. Inflammopharmacology 23:371–374CrossRef

Whitehouse M, Butters D, Vernon-Roberts B (2013) Ambivalent effects of thiocyanate upon the development and the inhibition of experimental arthritis in rats by aurothiomalate (Myocrysin) and metallic silver. Inflammopharmacology 21:291–300CrossRefPubMed

Titel: Our silver jubilee/anniversary 1991–2016
verfasst von: Michael Whitehouse
Publikationsdatum: 28.10.2016
Verlag: Springer International Publishing
Erschienen in: Inflammopharmacology / Ausgabe 6/2016
Print ISSN: 0925-4692
Elektronische ISSN: 1568-5608
DOI: https://doi.org/10.1007/s10787-016-0294-z

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2016

Plausible anti-inflammatory mechanism of resveratrol and caffeic acid against chronic stress-induced insulin resistance in mice

TRP channels: potential drug target for neuropathic pain

Proper balance of omega-3 and omega-6 fatty acid supplements with topical cyclosporine attenuated contact lens-related dry eye syndrome

Niflumic acid, a TRPV1 channel modulator, ameliorates stavudine-induced neuropathic pain

Origins of Inflammopharmacology. Twenty-five years on

Ameliorating chronic pain: opioids, adjunct and alternative therapies